REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/13/2025
Back to search
Official data from USPTO
PLASMACAP EBA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PLASMACAP EBA
ST13
US500000086019802Class
1, 5, 9, 37, 40, 41, 42
Filing
86019802
Registration
6172149
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
82
Latest update
10/14/2025
Trademark type
Word
Nice classes
1, 5, 9, 37, 40, 41, 42
Filing date
07/25/2013
Registration date
10/13/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/13/2020
Last transaction
10/14/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Mississauga, Ontario, CA
Examiner
BIBB,SCOTT
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Evolve Biologics Inc.,
Therapure Biopharma Inc.
Representatives
Christopher J. Schulte MERCHANT & GOULD P.C.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 37Class 40Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Resinspolysaccharide beads cross-linked to ligands for capturing proteins from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate ion exchangemixed modeaffinity resins
Class 5
Biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate for human clinical useplasma protein fractionsserum albuminimmunoglobulinscoagulation factorsantihemophilic factorsclotting factorsenzymescoenzymescoactivatorsinhibitorsstructural proteins
Class 9
Protein chromatography equipment for capturing biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate
Class 37
Construction of biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate; consulting services in the field of construction of biopharmaceutical and plasma manufacturing services
Class 40
Contract manufacturing services for others for biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate for research and developmentclinical use; consulting services concerning manufacturing of biologics
Class 41
Educational servicesdesigningarrangingconducting training programs for research and developmentmanufacturing of biologicsdesignconstructionuse of chromatography equipment
Class 42
Development of pharmaceutical preparations and medicinesdevelopment services for others for the capture of biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human bloodhuman blood plasmafractionated human blood plasmacryopastecryoprecipitate for research and developmentdesign of chromatography equipmentdesign of biopharmaceutical and plasma manufacturing facilitiesscientific research and evaluationengineering
Publications
History of USPTO decisions and trademark events.
82 publications found
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
07/06/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/01/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/13/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/28/2020
PUBO
PUBLISHED FOR OPPOSITION
07/28/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/18/2020
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
06/17/2020
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
06/17/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/02/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/01/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
12/03/2019
GNFR
FINAL REFUSAL E-MAILED
12/03/2019
CNFR
FINAL REFUSAL WRITTEN
12/03/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2019
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/24/2019
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/23/2019
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
10/22/2019
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/27/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/27/2019
CNSI
SUSPENSION INQUIRY WRITTEN
09/27/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/09/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/05/2019
GNSL
LETTER OF SUSPENSION E-MAILED
02/05/2019
CNSL
SUSPENSION LETTER WRITTEN
02/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
12/06/2018
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
06/08/2018
GNSI
INQUIRY TO SUSPENSION E-MAILED
06/08/2018
CNSI
SUSPENSION INQUIRY WRITTEN
06/08/2018
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/30/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/24/2017
GNSL
LETTER OF SUSPENSION E-MAILED
11/24/2017
CNSL
SUSPENSION LETTER WRITTEN
11/24/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/10/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/04/2017
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/20/2017
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/20/2017
CNSI
SUSPENSION INQUIRY WRITTEN
04/20/2017
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/17/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/13/2016
GNSL
LETTER OF SUSPENSION E-MAILED
09/13/2016
CNSL
SUSPENSION LETTER WRITTEN
09/13/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/16/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/08/2016
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
02/09/2016
GNSI
INQUIRY TO SUSPENSION E-MAILED
02/09/2016
CNSI
SUSPENSION INQUIRY WRITTEN
02/09/2016
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/16/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/30/2015
GNSL
LETTER OF SUSPENSION E-MAILED
05/30/2015
CNSL
SUSPENSION LETTER WRITTEN
05/30/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/23/2015
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
10/25/2014
GNSI
INQUIRY TO SUSPENSION E-MAILED
10/25/2014
CNSI
SUSPENSION INQUIRY WRITTEN
10/25/2014
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/24/2014
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/24/2014
GNSL
LETTER OF SUSPENSION E-MAILED
03/24/2014
CNSL
SUSPENSION LETTER WRITTEN
03/24/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/19/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2014
ALIE
ASSIGNED TO LIE
02/11/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/14/2013
GNRT
NON-FINAL ACTION E-MAILED
11/14/2013
CNRT
NON-FINAL ACTION WRITTEN
11/14/2013
DOCK
ASSIGNED TO EXAMINER
11/07/2013
MPMK
NOTICE OF PSEUDO MARK E-MAILED
07/31/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/30/2013
NWAP
NEW APPLICATION ENTERED
07/29/2013
Continuous trademark protection
Get notified about every new filing that threatens PLASMACAP EBA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.